donepezil has been researched along with Hydrocephalus, Normal Pressure in 1 studies
Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.
Hydrocephalus, Normal Pressure: A form of compensated hydrocephalus characterized clinically by a slowly progressive gait disorder (see GAIT DISORDERS, NEUROLOGIC), progressive intellectual decline, and URINARY INCONTINENCE. Spinal fluid pressure tends to be in the high normal range. This condition may result from processes which interfere with the absorption of CSF including SUBARACHNOID HEMORRHAGE, chronic MENINGITIS, and other conditions. (From Adams et al., Principles of Neurology, 6th ed, pp631-3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yusim, A | 1 |
| Anbarasan, D | 1 |
| Bernstein, C | 1 |
| Boksay, I | 1 |
| Dulchin, M | 1 |
| Lindenmayer, JP | 1 |
| Saavedra-Velez, C | 1 |
| Shapiro, M | 1 |
| Sadock, B | 1 |
1 review available for donepezil and Hydrocephalus, Normal Pressure
| Article | Year |
|---|---|
Normal pressure hydrocephalus presenting as Othello syndrome: case presentation and review of the literature.
Topics: Aged; Antipsychotic Agents; Cerebral Ventricles; Cholinesterase Inhibitors; Cognition Disorders; Cor | 2008 |